NCT06304805
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- First Affiliated Hospital Bengbu Medical College Bengbu, Anhui, China
Clinical trial condition
Non Small Cell Lung Cancer
Explore clinical trials studying Non Small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.
654 public trials
176 recruiting studies
Non Small Cell Lung Cancer trial results
Completed
Trial of Trametinib and Ponatinib in Patients With KRAS Mutant Advanced Non-Small Cell Lung Cancer
NCT03704688
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Cancer Center @ Suffolk (Limited protocol activity) Commack, New York, United States
Completed
Continued Access to RXDX-105
NCT03784378
- Conditions
- Adnexal Diseases, BRAF Gene Mutation, Bronchial Neoplasms, +24 more
- Locations
-
- Memorial Sloan Kettering Cancer Center 1275 York Avenue New York, United States
NCT04383938
- Conditions
- Advanced Solid Tumor, Bladder Cancer, Bronchial Neoplasms, +32 more
- Locations
-
- Mayo Clinic Phoenix, Arizona, United States
- Mayo Clinic Jacksonville, Florida, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana Farber Cancer Center Boston, Massachusetts, United States
NCT04925284
- Conditions
- Adnexal Diseases, Breast Diseases, Breast Neoplasms, +57 more
- Locations
-
- Exelixis Clinical Site #48 Birmingham, Alabama, United States
- Exelixis Clinical Site #20 Tucson, Arizona, United States
- Exelixis Clinical Site#95 Tucson, Arizona, United States
- Exelixis Clinical Site#58 Little Rock, Arkansas, United States
NCT03894618
- Conditions
- Adenocarcinoma, Anus Diseases, Anus Neoplasms, +68 more
- Locations
-
- The Sarah Cannon Research Institute Nashville, Tennessee, United States
- The University of Texas MD Anderson Cancer Center Houston, Texas, United States
- Leuven Cancer Institute Leuven, Belgium
- Princess Margaret Cancer Center Toronto, Ontario, Canada
Completed
Phase II Concurrent Durvalumab and Radiotherapy for for Stage III Non-Small Cell Lung Cancer
NCT04003246
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
- Locations
-
- Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas Dallas, Texas, United States
NCT03195699
- Conditions
- Advanced Cancer, Breast Cancer, Breast Diseases, +42 more
- Locations
-
- The University of Texas MD Anderson Cancer Center Houston, Texas, United States
- Mays Cancer Center at University of Texas Health Science Center SA San Antonio, Texas, United States
Completed
TGRX-326 Pharmacokinetic Mass Balance
NCT06438367
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
NCT03190174
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +68 more
- Locations
-
- Sarcoma Oncology Research Center Santa Monica, California, United States